Could “The Stock Genome Project” Win a Nobel Prize?

Financial tech firm maps out the DNA of 50,000 stocks and funds

Dear Reader, Let’s face it… When it comes to investing — you’re stuck in the stone age. If you’re like most folks, you’re probably relying on news articles and "gut instinct” to make your trades… Meanwhile, Wall Street is spending millions of dollars on cutting edge tools you’ll never have access to. That’s why big Wall Street traders had record years in 2022 — while the average investor was losing money. It’s completely unfair. But today, that all changes… Because my team and I just unveiled a groundbreaking new system. We call it the Stock Genome Project. And it’s already putting some of the world’s best investors to shame. To put it simply… We’ve created an $18 million supercomputer to sequence the “DNA” of over 50,000 stocks, funds and ETFs… And we can now predict which way stocks will move with incredible accuracy. In fact, our system was able to predict gains of 259%, 188%, and 311% last year — even as the overall markets were in turmoil. This is Wall Street Caliber technology for the Main Street American. And you can try it out for yourself right now. We revealed all the details in a recent interview. Click here to watch it now for free. Keith Kaplan CEO, TradeSmith P.S. This could change the way you invest forever. You’re not going to want to miss this. Click here to watch now.   ©2023 TradeSmith, LLC. All Rights Reserved. P.O. Box 340087 Tampa, FL 33694 To unsubscribe or change your email preferences, please click here. Terms of Use  |  Privacy Policy